GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Mukka Proteins Ltd

Mukka Proteins Board Meeting Scheduled for Q2 FY27 Unaudited Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 02 Nov 2026, 04:59 PM IST  ·  BSE ID: 869d6b1e-6fbc-4d76-a74f-68cfed9e3ae5
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on November 7, 2026, to review and approve its financial results for the latest quarter.
🤖 AI Summary
  • Mukka Proteins' Board meeting is scheduled for Saturday, November 7, 2026.
  • The Board will consider and approve unaudited financial results for Q2 FY27 and half-year ended September 30, 2026.
  • Both standalone and consolidated financial results will be presented for approval.
  • Trading window for designated persons closed on October 1, 2026, due to results consideration.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation of a Board meeting.
👤
Who Is Affected
Shareholders are generally affected by the eventual financial results, which will be considered in this meeting, rather than the meeting intimation itself. Designated persons and their immediate relatives are impacted by the trading window closure.
🔍
Management Signal
Management is adhering to regulatory requirements by intimating the Board meeting and implementing a trading window closure prior to the declaration of financial results.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Mukka Proteins' Q2 FY27 financial results — check revenue and profit figures.
Mukka Proteins' half-year FY27 financial results — analyze performance for the six-month period.
Any further Board decisions from the November 7, 2026 meeting — monitor regulatory filings.
LOW RISK This filing is a routine intimation of a board meeting for results, posing no immediate financial or operational risk.
💡 Investor Takeaway
Mukka Proteins Ltd has scheduled a Board meeting for November 7, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. This intimation confirms the date for upcoming financial disclosure.
📅 Company Track Record
A previous filing on May 12, 2026, indicated a Board meeting for Mukka Proteins to consider FY26 results and Rs. 75 Cr NCDs on May 15, 2026. This current filing is a similar intimation for the upcoming quarterly results consideration.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Mukka Proteins Ltd's Board meeting scheduled?
Mukka Proteins Ltd's Board of Directors meeting is scheduled for Saturday, November 7, 2026.
What will be discussed at Mukka Proteins Ltd's Board meeting on November 7, 2026?
The Board will consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.
When did the trading window close for Mukka Proteins Ltd?
The trading window for designated persons and their immediate relatives closed with effect from Thursday, October 1, 2026.
When will the trading window reopen for Mukka Proteins Ltd?
The trading window will reopen 48 hours after the declaration of the financial results.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.